World’s first congenital pituitary hypoplasia model developed using patient-derived iPS cells

Researchers at Kobe University’s Graduate School of Medicine have developed the world’s first congenital pituitary hypoplasia (CPH) model using patient-derived iPS cells. The research group consisting of Associate Professor TAKAHASHI Yutaka, medical researcher Matsumoto Ryusaku and Professor Aoi Takashi et al. succeeded in using the model to illuminate the mechanisms underlying CPH. The team has been attempting to apply this model to other pituitary diseases and drug discovery.
Read More

Increasing the possibility of early diagnosis for neuro-developmental disorders

DGIST researchers have identified the causes of hypersensitivity accompanied by neurodevelopmental disorders such as autism-spectrum disorder (ASD). This is expected to make huge contributions to the early diagnosis of sensory-defective symptoms accompanying neurodevelopmental disorders and cancer as well as the improvement of anti-cancer drug side effects.
Read More

Radiation therapy to heart can worsen fatigue, shortness of breath in cancer patients

Radiation doses to the heart that occur during radiation therapy treatments for lung cancer, breast cancer and lymphoma can increase fatigue, cause difficulty breathing and lower capacity for physical activity in patients with cancer, according to research presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course. The course examines new science and best practices in assessing, diagnosing and treating the unique cardiovascular concerns of patients with cancer and/or those requiring survivorship care.
Read More